FDA Looks to Open Up the Medicine Cabinet

June 25, 2009

The Food and Drug Administration Transparency Task Force held the first of its two public meetings for public recommendations on how to increase transparency in decision making yesterday. At the meeting, Kristi Zonno, Director of Genetics and Health Policy at the advocacy group Genetic Alliance called for FDA to create a public registry of “genetic, genomic, and pharmacogenomics testing available to the U.S. market,” as well as make warning letters to pharmaceutical companies public in real time. (Science Progress)